Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioconjugate Chemistry|June 18, 2010
Hybrid PET/CT for noninvasive pharmacokinetic evaluation of dynamic PolyConjugates, a synthetic siRNA delivery systemSarah R Mudd, Vladimir S Trubetskoy, Andrei V Blokhin, et al.
Molecular Imaging and Biology|October 24, 2015
Image quality of Zr-89 PET imaging in the Siemens microPET Focus 220 preclinical scannerTyler J Bradshaw, Martin J Voorbach, David R Reuter, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2019
Utilization of <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In VivoSarah R Mudd, Martin J Voorbach, Dong Cheng, et al.
Drug Discovery Today|October 4, 2016
Molecular imaging in oncology drug developmentSarah R Mudd, Robert A Comley, Mats Bergstrom, et al.
Academic Radiology|February 19, 2008
Reproducibility of tumor volume measurement at microCT colonography in living miceBenjamin Y Durkee, Sarah R Mudd, Calista N Roen, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 11, 2013
Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2Shundong Ji, Yang Zhou, Martin J Voorbach, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2012
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft modelSarah R Mudd, Martin J Voorbach, David R Reuter, et al.
Physics in Medicine and Biology|March 9, 2012
Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLTJoseph J Grudzinski, John M Floberg, Sarah R Mudd, et al.
Translational Oncology|September 1, 2023
Evaluation of a semi-automated approach for FDG PET image analysis for routine clinical application in patients with multiple myelomaTyler J Wellman, Sarah R Mudd, Kelly N Godby, et al.
Pageof 2